Second cite

Clinical and Experimental Dermatology

Volumn 31, Issue 5, 2006, Pages 724-726

  White, I R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HAIR DYE; HYDROGEN PEROXIDE; PHENYLENEDIAMINE; PHENYLENEDIAMINE DERIVATIVE;

CONTACT ALLERGY; DERMATITIS; DRUG INDUSTRY; HUMAN; PATCH TEST; PRIORITY JOURNAL; RISK ASSESSMENT; SHORT SURVEY; SKIN MANIFESTATION; SKIN TEST; FEMALE; MALE; NEOPLASM; REVIEW; SKIN ALLERGY;

DERMATITIS, ALLERGIC CONTACT; FEMALE; HAIR DYES; HUMANS; MALE; NEOPLASMS; PATCH TESTS; PHENYLENEDIAMINES;

EID: 33746172578     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2006.02226.x     Document Type: Short Survey

References (18)

1. European Commission. Council Directive of 27 July 1976 on the Approximation of the Laws of the Member States Relating to Cosmetic Products. Available at: http://eur-lex.europa.eu/LexUriServ/site/en/consleg/1976/L/ 01976L0768-20051125-en.pdf (accessed 7 June 2006).
2. European Commission. Inventory of Ingredients: Ingredients Oredered by INCI Name. Available at: http://ec.europa.eu/enterprise/cosmetics/inci/ inci_2006.pdf (accessed 7 June 2006).
3. Gago-Dominguez M, Castelao JE, Yuan J-M, Yu MC, Ross RK. Use of permanent hair dyes and bladder-cancer risk. Int J Cancer 2001; 91: 575-9.
4. Miller AB, Bartsch H. Hair dye use and bladder cancer. Int J Cancer 2001; 94: 901-2.
5. Andrew AS, Schned AR, Heaney JA, Karagas MR. Bladder cancer risk and personal hair dye use. Int J Cancer 2004; 109: 581-6.
6. Kogevinas M, Fernandez F, Garcia-Closas M et al. Hair dye use is not associated with risk for bladder cancer: Evidence from a case-control study in Spain. Eur J Cancer 2006; 42: epub.
7. Pelucchi C, Bosetti C, Negri E et al. Mechanisms of disease: the epidemiology of bladder cancer. Nature Clin Prac Urol 2006; 3: 327-10.
8. Benavente Y, Garcia N, Domingo-Domenech E et al. Regular use of hair dyes and risk of lymphoma in Spain. Int J Epidemiol 2005; 34: 1118-22.
9. European Commission. Scientific Committee on Consumer Products. Opinion on Personal Use of Hair Dyes and Cancer Risk. http://ec.europa.eu/health/ ph_risk/committees/04_sccp/docs/sccp_o_001.pdf. 20 September 2005 (accessed 7 June 2006).
10. Khumalo NP, Jessop S, Ehrlich R. Prevalence of cutaneous adverse effects of hairdressing: a systematic review. Arch Dermatol 2006; 142: 377-83.
11. Sosted H, Hesse U, Menne T et al. Contact allergy to hair dyes in a Danish adult population: an interview-based study. Br J Dermatol 2005; 153: 132-5.
12. McFadden JP, Jefferies D, Jowsey I et al. Incidence and prevalence of contact allergy to the permanent hair dye agent para-phenylenediamine - results of the Anglo-Thai study. Br J Dermatol 2006; 155 (Suppl. 1): 1-9.
13. Hillen U, Jappe U, Frosch PJ et al. Late reactions to the patch-test preparations para-phenylenediamine and epoxy resin: a prospective multicentre investigation of the German Contact Dermatitis Research Group. Br J Dermatol 2006; 154: 665-70.
14. McFadden JP, White IR, Johansen J, Bruze M. Should paraphenylenediamine (PPD) 1% pet. be part of commercially available standard series? Contact Dermatitis 2005; 53: 183.
15. Diepgen TL, Coenraads PJ, Wilkinson M et al. Paraphenylendiamine (PPD) 1% pet. is an important allergen in the standard series. Contact Dermatitis 2005; 53: 185.
16. Becker D, Mahler V, Szliska C et al. The concentration of para-phenylenediamine (PPD) for routine patch testing in a standard series needs to be redefined. Contact Dermatitis 2005; 53: 186.
17. Gawkrodger DJ, English JSC. How safe is patch testing to PPD? Br J Dermatol 2006; 154: 1025-7.
18. Krasteva M, Cottin M, Cristaudo A et al. Sensitivity and specificity of the consumer open skin allergy test as a method of prediction of contact dermatitis to hair dyes Eur J Dermatol 2005; 15: 18-25.